Our phone:
Toll free (US):
Other languages:
Buy Vytorin, English / PoundsAchetez Vytorin, Francäis / EurosKaufen Vytorin, Deutsch / EurosCompre Vytorin, Español / EurosCompare Vytorin, Italiano / EurosComprar Vytorin, Portuguesa / Euros Vytorin, English / Euros Vytorin, Español / US Dollars Vytorin, Portuguesa / US Dollars Vytorin, Francäis / US Dollars
Home
Get free sample
tablets with your order
Your cart:
$0.00 (0 items) | Checkout

Categories list

Vytorin

Generic Vytorin

Simvastatin Ezetimibe 10mg + 10/20mg + 10mg
Cholesterol

Brand(s): Simvotin

Manufacturer: Ranbaxy

PackagePer pillPriceOrder
10mg + 10mg × 30 pills$3.06$91.90Buy Now!
10mg + 10mg × 60 pills$2.75$164.90Buy Now!
10mg + 10mg × 90 pills$2.40$215.90Buy Now!
10mg + 10mg × 120 pills$2.27$271.90Buy Now!

PackagePer pillPriceOrder
20mg + 10mg × 30 pills$4.20$125.90Buy Now!
20mg + 10mg × 60 pills$3.88$232.90Buy Now!
20mg + 10mg × 90 pills$3.59$322.90Buy Now!
- Most popular quantity.
 

Product Info »

Buying drugs the way we see it

Top quality medications
Bargain prices
Secure ordering
Worldwide shipping
24/7/365 Customer Support
100% Satisfaction Guarantee

What is a generic pill?

Very often our web site visitors ask us about generic medications. In this section we have placed some useful information about generic pills in general and about the ones we have in our product list. Click here

QUICKSEARCH
By keyword:
By tablets name:

News

Vytorin's label gets makeover to include SHARP results - Cardiovascular Business

Vytorin's label gets makeover to include SHARP resultsCardiovascular BusinessThe FDA has approved an updated label for Merck's Vytorin (ezetimibe/simvastatin) that includes results from the SHARP trial

FDA Allows Vytorin Labeling for Use in Kidney Disease - MedPage Today

FDA Allows Vytorin Labeling for Use in Kidney DiseaseMedPage TodayBy Chris Kaiser, Cardiology Editor, MedPage Today The FDA has approved new labeling for the single-tablet combination of ezetimibe-simvastatin (Vytorin), a cholesterol-lowering drug, for use in patients with moderate to severe chronic kidney disease

Vytorin Falls Short of New Indication for CKD Patients - Family Practice News Digital Network

Vytorin Falls Short of New Indication for CKD PatientsFamily Practice News Digital NetworkThe Food and Drug Administration approved a revised label for Vytorin that now includes data from a study showing a benefit of treatment in patients with moderate to severe kidney disease, but the agency did not approve a new indication that reflects

Merck Swings to Profit on Fewer Charges, Sales Growth - Wall Street Journal

Globe and MailMerck Swings to Profit on Fewer Charges, Sales GrowthWall Street JournalSales of cholesterol drug Vytorin declined 16%, though a related drug, Zetia, gained 2%

Articles

Did not find the product you were looking for?

Have some suggestion concerning our site, product or services? Please leave here a note. We will do our best to add the product you are interested in or take your suggestion into consideration.

bookmark Bookmark this site
Special Offer!

Our billing is certified by:

Secure shopping certificates